Novavax Inc

NVV1.SG·Stuttgart
Compare
9.54+0.13 (+1.38%)today
As of Nov 5, 11:16 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close9.41
Open9.47
Day range9.399.54
52-week range5.4211.86
Off day high0.00%
Off 52-week high−19.56%
Volume0.00
Avg. volume (3M)1.37K
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding—
Short interest—
Earnings dateNov 5, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
NVV1.SG 194700.KQ 300142.SZ PCVX BAVA.CO 6547.TWO
Market cap — 157.84B 18.70B 10.04B 18.52B 15.63B
P/E (TTM) — — 1,169.0 — 12.7 —
Forward P/E — — 26.0 -9.0 22.1 32.6
Price/book — — 2.7 3.1 1.4 4.4
Dividend yield — 4.52% 1.35% — — —
1-year change +29.02% −48.90% −6.23% +57.47% +31.98% +42.31%
Today +1.38% +0.45% +2.19% −2.85% +0.57% −2.16%

The closest companies by business. Prices may be delayed up to 20 min.

Latest news

All NVV1.SG news ›
StockStory·Positive

Novavax (NVAX) reports earnings tomorrow: what to expect

Vaccine biotechnology company Novavax (NASDAQ:NVAX) will be reporting earnings this Thursday before market hours. Here’s what you need to know. Novavax beat analysts’ revenue expectations last quarter, reporting revenues of $56.7 million,…

AOL.com··2 outletsPositive

Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe

Novavax (Nasdaq: NVAX) has earned a $125 million milestone payment with the initiation (fifth patient dosed) of Sanofi's Phase 3 influenza-COVID-19 combination vaccine trial utilizing Novavax's ... The global flu and COVID-19 markets have…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

38mentions in 30 days
38with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 38 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance